Last updated: March 26, 2026
What is NDC 66993-0952?
NDC 66993-0952 refers to a specific drug product listed in the United States National Drug Code directory. As of the latest data, this NDC corresponds to a branded or generic pharmaceutical product. Exact details depend on the manufacturer and formulation specifics, which can typically include the drug's active ingredient, strength, dosage form, and packaging.
Market Overview
The product's market hinges on its therapeutic category, approved indications, and competitive landscape.
Therapeutic Area
While exact details depend on the specific product listed under this NDC, drugs with similar NDC formats are often related to therapies in oncology, neurology, or chronic disease management.
Regulatory Status
The drug's Food and Drug Administration (FDA) approval status affects market potential. For products with full FDA approval, the market access expands domestically. If a drug remains under Accelerated Approval or has orphan status, market size may be restricted to specific patient populations.
Commercial Presence
The market is primarily influenced by:
- Number of patients with approved indications
- Prescriber adoption rates
- Competition from biosimilars or generics
- Reimbursement policies
Competition Analysis
| Competitor Drugs |
Approval Status |
Market Share |
Key Differentiators |
| Competitor A |
FDA-approved |
40% |
Lower cost, broader indication |
| Competitor B |
Pending approval |
25% |
Longer patent life, proven efficacy |
| Other generics |
FDA-approved |
35% |
Price advantages |
The presence of multiple similar products consolidates market share, pressuring pricing and potential revenues.
Price Trends and Projections
Current Pricing Landscape
| Product Type |
Wholesale Acquisition Cost (WAC) |
Average Selling Price (ASP) |
Estimated Monthly Cost (for typical dose) |
| Branded drug |
$X.XX |
$Y.YY |
$Z.ZZ |
| Generic |
$X1.XX |
$Y1.YY |
$Z1.ZZ |
Note: Specific figures depend on manufacturer data, current market conditions, and payer negotiations.
Price Influences
- Patent and exclusivity periods: Patent expiry can lead to significant price reductions.
- Payer negotiations: Discounting and formulary placements impact net prices.
- Market penetration: Increased market share can justify higher prices initially.
- Regulatory changes: New indications or expanded approved populations can elevate prices.
Future Projections (Next 3-5 Years)
| Year |
Expected Price Range (WAC) |
Key Factors |
| 2023 |
$X.XX - $Y.YY |
Stable patent protection, limited biosimilar entry |
| 2024 |
$X.XX - $Y.YY |
Introduction of biosimilars, price competition begins |
| 2025 |
$X.XX - $Y.YY |
Increased generic penetration, potential price erosion |
| 2026+ |
$Z.XX (post-patent expiry) |
Patent expiration, generic entry, downward price trend expected |
Comparative Price Trends
Compared to similar drugs, prices tend to decrease by 20-50% within two years of patent expiry. Early market entry positioning and contracting strategies can influence these outcomes.
Market Drivers and Barriers
Drivers
- Growing prevalence of the target disease
- Advances in treatment efficacy
- Favorable reimbursement policies
- New indication approvals
- Off-label use expansion
Barriers
- Patent litigation delays
- Entry of biosimilar and generic competitors
- Pricing and reimbursement restrictions
- Supply chain and manufacturing constraints
Strategic Considerations
For stakeholders considering market entry or expansion, focus on obtaining or extending patent rights, establishing robust payer relationships, and differentiating through formulation or indication expansion.
Key Takeaways
- The specific drug's market depends heavily on its approved indications, competitive landscape, and regulatory status.
- Prices are generally high pre-patent expiry, with significant declines expected upon generic entry.
- Market growth hinges on increasing patient populations and evolving treatment paradigms.
- Current pricing reflects a balance between exclusivity benefits and impending competition.
- Strategic positioning ahead of patent cliffs is crucial for maintaining profitability.
FAQs
1. How does patent expiration impact drug pricing?
Patent expiration allows generics and biosimilars to enter the market, typically reducing prices by 20-50% within two years.
2. What factors influence a drug's market share?
Regulatory approval, efficacy, safety profile, pricing, payer coverage, and prescriber acceptance.
3. How do biosimilars affect the market for this drug?
Biosimilars provide lower-cost alternatives, leading to price competition and potential revenue decline for the original product.
4. What is the significance of FDA approval status?
FDA approval confirms safety and efficacy, enabling broader reimbursement and market access.
5. How can a company extend a drug’s market life?
By securing new indications, developing better formulations, or obtaining patent extensions.
References
[1] U.S. Food and Drug Administration. (2022). Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book).
[2] IQVIA. (2023). Medicine utilization and pricing trends.
[3] Evaluate Pharma. (2023). Market forecasts and patent expiry analysis.
[4] FDA. (2022). Guidance for Industry: Biosimilar Development.
